Challenges of Managing Lower Urinary Tract Symptoms in Women with Tamoxifen Use
Objective: Tamoxifen complicates management of conditions such as urinary tract infections (UTIs), urinary incontinence (UI), and/or pelvic organ prolapse (POP) that traditionally benefit from hormonal intake; thus, we reviewed our experience in managing these hormonally deprived women. Materials an...
Main Authors: | Ethan M. Fan, Philippe E. Zimmern |
---|---|
Format: | Article |
Language: | English |
Published: |
Mary Ann Liebert
2022-04-01
|
Series: | Women's Health Reports |
Subjects: | |
Online Access: | https://www.liebertpub.com/doi/full/10.1089/WHR.2021.0147 |
Similar Items
-
Clinical and Urodynamic Predictors of the Q-Tip Test in Women With Lower Urinary Tract Symptoms
by: Chin-Jui Wu, et al.
Published: (2020-03-01) -
Prevalence of Double Incontinence and Lower Urinary Tract Symptoms in Patients with Fecal Incontinence: A Single-center Observational Study
by: Tatsuya Abe, et al.
Published: (2024-01-01) -
Complications of treatment of urinary incontinence and pelvic organ prolapse
by: Chasta Bacsu, MD, et al.
Published: (2013-03-01) -
Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
by: Sara Wawrysiuk, et al.
Published: (2022-12-01) -
Correlation of severity of pelvic organ prolapse with lower urinary tract symptoms
by: Yun-Han Liao, et al.
Published: (2021-01-01)